Multi-omics profiling uncovers candidate genes for the treatment of graves’ disease
This study provides novel insights into GD pathogenesis, highlighting AGER and AIF1 as therapeutically relevant genes. Findings offer valuable insights for GD treatment strategies and potential drug development streamlining, warranting further experimental validation.
Authors
- Zifang Zheng (ORCID: https://orcid.org/0009-0000-8735-6373)
- Jian Gao (ORCID: https://orcid.org/0000-0002-6317-963X)
- Guolie Zhang
Institutions
- Putian University (CN)
Publication Details
- Journal
- Immunopharmacology and Immunotoxicology
- Published
- 2025-12-22
- DOI
- https://doi.org/10.1080/08923973.2025.2603439
- Primary Topic
- Genomics and Rare Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00